These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38605969)

  • 1. The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives.
    Stallmach A; Quickert S; Puta C; Reuken PA
    Front Immunol; 2024; 15():1352744. PubMed ID: 38605969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
    König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK
    Front Immunol; 2021; 12():628741. PubMed ID: 35046929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications.
    Varesi A; Deumer US; Ananth S; Ricevuti G
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
    Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR
    Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.
    Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S
    Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.
    Jurek JM; Castro-Marrero J
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
    Lupo GFD; Rocchetti G; Lucini L; Lorusso L; Manara E; Bertelli M; Puglisi E; Capelli E
    Sci Rep; 2021 Mar; 11(1):7043. PubMed ID: 33782445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review.
    Wang JH; Choi Y; Lee JS; Hwang SJ; Gu J; Son CG
    Eur J Med Res; 2024 Mar; 29(1):148. PubMed ID: 38429822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study.
    Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.
    Wallis A; Ball M; Butt H; Lewis DP; McKechnie S; Paull P; Jaa-Kwee A; Bruck D
    J Transl Med; 2018 Feb; 16(1):24. PubMed ID: 29409505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
    Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients.
    Vogl T; Kalka IN; Klompus S; Leviatan S; Weinberger A; Segal E
    Sci Adv; 2022 Sep; 8(38):eabq2422. PubMed ID: 36149952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.
    Arron HE; Marsh BD; Kell DB; Khan MA; Jaeger BR; Pretorius E
    Front Immunol; 2024; 15():1386607. PubMed ID: 38887284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
    Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
    Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
    medRxiv; 2022 Jan; ():. PubMed ID: 35043127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Corbitt M; Campagnolo N; Staines D; Marshall-Gradisnik S
    Probiotics Antimicrob Proteins; 2018 Sep; 10(3):466-477. PubMed ID: 29464501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.